modified REGENESIS

Related by string. * modifier . MODIFIED . Modifier . Modified : genetically modified crops . genetically modified GM . lap SK Modified . genetically modified organisms GMOs . Block Modified . genetically modified organisms / ReGenesis . Regenesis : modified REGENESIS Phase IIb . Regenesis Power . REGENESIS Phase IIb . Regenesis Biomedical . Regenesis Management . Phase IIb REGENESIS * *

Related by context. Frequent words. (Click for all words.) 53 DP b# 52 PRECISE 51 multimodality 50 phase IIa 50 ABSORB trial 50 ThermoDox R 49 multicenter prospective 49 anti arrhythmic 48 prospective multicenter 48 PFO closure 48 cortical stimulation 48 Carotid 48 Cardiac Resynchronization Therapy 47 phase IIa clinical 47 Hexvix 47 ABSORB 47 stereotactic body 47 nonrandomized 47 neuroprotectant 47 thrombolytic therapy 47 Acute Ischemic Stroke 47 Trofex 47 Onko Sure ® 46 desmoteplase 46 ThermoDox 46 photodynamic therapy PDT 46 coronary intervention 46 FT# [001] 46 TH# [003] 46 orBec 46 prospective randomized controlled 46 ASSERT 46 phase IIb clinical 46 QTinno 46 RE LY 46 multicenter clinical 45 intracoronary 45 Desmoteplase 45 ZD# [001] 45 Microvolt T Wave Alternans 45 carotid stent 45 alteplase 45 extracranial 45 Acute Myocardial Infarction 45 Cerovive 45 randomized multicenter 45 Roflumilast 45 PMA submission 45 Thrombolysis 45 Zemiva 45 vascular disrupting agent 45 Multicenter 45 SCD HeFT 45 drug eluting stent DES 45 Phase Ib clinical 45 phase Ib 45 ongoing Phase 1b 45 Retisert 44 Photocure 44 Chronic Heart Failure 44 placebo controlled clinical 44 cardiac resynchronization 44 REG1 44 efficacy endpoint 44 TAXUS Liberte Stent 44 Phase IIb clinical 44 Phase Ib II 44 SEPET TM 44 rFVIIa 44 preclinical efficacy 44 acute coronary syndromes ACS 44 EVEREST II 44 ILLUMINATE 44 Phase IIb 44 PROSTVAC TM 44 OMS# 44 multiple myeloma MM 44 Delcath PHP System 44 GV# [001] 44 Dendreon Provenge 44 deforolimus 44 ivabradine 44 NTx TM -# 44 ximelagatran 44 IPX# 44 olmesartan 44 Urocidin 44 MERLIN TIMI 43 ASCT 43 EP# [003] 43 randomized Phase III 43 NYSE PHG AEX PHI 43 tanespimycin 43 efficacy tolerability 43 eprotirome 43 carotid artery stenting 43 Aliskiren 43 VIAject 43 Magnetic resonance 43 Retisert TM 43 Pirfenidone

Back to home page